APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iloperidone Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Iloperidone Drugs Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry ResearchIloperidone Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Iloperidone Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Iloperidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iloperidone Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Iloperidone Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Iloperidone Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Iloperidone Drugs include Alembic Pharmaceuticals, CSPC, Hansoh Pharma, Inventia, Taro Pharmaceutical and Vanda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Iloperidone Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Iloperidone Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Iloperidone Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Iloperidone Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Iloperidone Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Iloperidone Drugs Market by Company

Alembic Pharmaceuticals

CSPC

Hansoh Pharma

Inventia

Taro Pharmaceutical

Vanda

Iloperidone Drugs Segment by Type

Brand Drugs

Generic Drugs

Iloperidone Drugs Segment by Application

Schizophrenia

Others

Iloperidone Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iloperidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iloperidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iloperidone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Iloperidone Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Iloperidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Brand Drugs Table 2. Major Company of Generic Drugs Table 3. Global Iloperidone Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Iloperidone Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Iloperidone Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Iloperidone Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Iloperidone Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Iloperidone Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Iloperidone Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Iloperidone Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Iloperidone Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Iloperidone Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Iloperidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Iloperidone Drugs Industry Trends Table 25. Iloperidone Drugs Industry Drivers Table 26. Iloperidone Drugs Industry Opportunities and Challenges Table 27. Iloperidone Drugs Industry Restraints Table 28. Global Iloperidone Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Iloperidone Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Iloperidone Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Iloperidone Drugs Sales Share by Company (2021-2026) Table 32. Global Iloperidone Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Iloperidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Iloperidone Drugs Major Company Production Sites and Headquarters Table 35. Global Iloperidone Drugs Company, Product Type & Application Table 36. Global Iloperidone Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Iloperidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Iloperidone Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Iloperidone Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Iloperidone Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Iloperidone Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Iloperidone Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Iloperidone Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Iloperidone Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Iloperidone Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Iloperidone Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Iloperidone Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Iloperidone Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Iloperidone Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Iloperidone Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Iloperidone Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Iloperidone Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Iloperidone Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Iloperidone Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Iloperidone Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Iloperidone Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Iloperidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Alembic Pharmaceuticals Company Information Table 72. Alembic Pharmaceuticals Business Overview Table 73. Alembic Pharmaceuticals Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alembic Pharmaceuticals Iloperidone Drugs Product Portfolio Table 75. Alembic Pharmaceuticals Recent Development Table 76. CSPC Company Information Table 77. CSPC Business Overview Table 78. CSPC Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CSPC Iloperidone Drugs Product Portfolio Table 80. CSPC Recent Development Table 81. Hansoh Pharma Company Information Table 82. Hansoh Pharma Business Overview Table 83. Hansoh Pharma Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hansoh Pharma Iloperidone Drugs Product Portfolio Table 85. Hansoh Pharma Recent Development Table 86. Inventia Company Information Table 87. Inventia Business Overview Table 88. Inventia Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Inventia Iloperidone Drugs Product Portfolio Table 90. Inventia Recent Development Table 91. Taro Pharmaceutical Company Information Table 92. Taro Pharmaceutical Business Overview Table 93. Taro Pharmaceutical Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Taro Pharmaceutical Iloperidone Drugs Product Portfolio Table 95. Taro Pharmaceutical Recent Development Table 96. Vanda Company Information Table 97. Vanda Business Overview Table 98. Vanda Iloperidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Vanda Iloperidone Drugs Product Portfolio Table 100. Vanda Recent Development Table 101. North America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 103. North America Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 104. North America Iloperidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Iloperidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 106. North America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Iloperidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Iloperidone Drugs Market Share by Country (2021-2026) Table 109. North America Iloperidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Iloperidone Drugs Market Share Forecast by Country (2027-2032) Table 111. Europe Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 113. Europe Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 114. Europe Iloperidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Iloperidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Iloperidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Iloperidone Drugs Market Share by Country (2021-2026) Table 119. Europe Iloperidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Iloperidone Drugs Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Iloperidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Iloperidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Iloperidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Iloperidone Drugs Market Share by Country (2021-2026) Table 129. Asia-Pacific Iloperidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Iloperidone Drugs Market Share Forecast by Country (2027-2032) Table 131. Latin America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 133. Latin America Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 134. Latin America Iloperidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Iloperidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Iloperidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Iloperidone Drugs Market Share by Country (2021-2026) Table 139. Latin America Iloperidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Iloperidone Drugs Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Iloperidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Iloperidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Iloperidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Iloperidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Iloperidone Drugs Market Share by Country (2021-2026) Table 149. Middle East and Africa Iloperidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Iloperidone Drugs Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Iloperidone Drugs Distributors List Table 154. Iloperidone Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Iloperidone Drugs Image Figure 2. Global Iloperidone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iloperidone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Iloperidone Drugs Sales (2021-2032) & (K Units) Figure 5. Brand Drugs Image Figure 6. Global Brand Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drugs Image Figure 8. Global Generic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Iloperidone Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Iloperidone Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Iloperidone Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Iloperidone Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Iloperidone Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Iloperidone Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Iloperidone Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Iloperidone Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Iloperidone Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Iloperidone Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Iloperidone Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Iloperidone Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Iloperidone Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Schizophrenia Image Figure 24. Global Schizophrenia Sales YoY Growth (2021-2032) & (K Units) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Iloperidone Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Iloperidone Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Iloperidone Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Iloperidone Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Iloperidone Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Iloperidone Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Iloperidone Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Iloperidone Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Iloperidone Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Iloperidone Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Iloperidone Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Iloperidone Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Iloperidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Iloperidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Iloperidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Iloperidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Iloperidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Iloperidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Iloperidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Iloperidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Iloperidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Iloperidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Iloperidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Iloperidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Iloperidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Iloperidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Iloperidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Iloperidone Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Iloperidone Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drugs
  • Generic Drugs
Applications
  • Schizophrenia
  • Others
Companies covered
  • Alembic Pharmaceuticals
  • CSPC
  • Hansoh Pharma
  • Inventia
  • Taro Pharmaceutical
  • Vanda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iloperidone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Iloperidone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Iloperidone Drugs Market by Type
  6. 1.3.1 Brand Drugs
  7. 1.3.2 Generic Drugs
  8. 1.4 Global Iloperidone Drugs Market Size by Type
  9. 1.4.1 Global Iloperidone Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Iloperidone Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Iloperidone Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Iloperidone Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Iloperidone Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Iloperidone Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Iloperidone Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Iloperidone Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Iloperidone Drugs Industry Trends
  2. 2.2 Iloperidone Drugs Industry Drivers
  3. 2.3 Iloperidone Drugs Industry Opportunities and Challenges
  4. 2.4 Iloperidone Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Iloperidone Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Iloperidone Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Iloperidone Drugs Price (2021-2026)
  4. 3.4 Global Iloperidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Iloperidone Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Iloperidone Drugs Company, Product Type & Application
  7. 3.7 Global Iloperidone Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Iloperidone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Iloperidone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Iloperidone Drugs Tier 1, Tier 2, and Tier 3
4 Iloperidone Drugs Regional Status and Outlook
  1. 4.1 Global Iloperidone Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Iloperidone Drugs Historic Market Size by Region
  3. 4.2.1 Global Iloperidone Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Iloperidone Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Iloperidone Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Iloperidone Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Iloperidone Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Iloperidone Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Iloperidone Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Iloperidone Drugs by Application
  1. 5.1 Iloperidone Drugs Market by Application
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Others
  4. 5.2 Global Iloperidone Drugs Market Size by Application
  5. 5.2.1 Global Iloperidone Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Iloperidone Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Iloperidone Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Iloperidone Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Iloperidone Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Iloperidone Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Iloperidone Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Iloperidone Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alembic Pharmaceuticals
  2. 6.1.1 Alembic Pharmaceuticals Company Information
  3. 6.1.2 Alembic Pharmaceuticals Business Overview
  4. 6.1.3 Alembic Pharmaceuticals Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alembic Pharmaceuticals Iloperidone Drugs Product Portfolio
  6. 6.1.5 Alembic Pharmaceuticals Recent Developments
  7. 6.2 CSPC
  8. 6.2.1 CSPC Company Information
  9. 6.2.2 CSPC Business Overview
  10. 6.2.3 CSPC Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Iloperidone Drugs Product Portfolio
  12. 6.2.5 CSPC Recent Developments
  13. 6.3 Hansoh Pharma
  14. 6.3.1 Hansoh Pharma Company Information
  15. 6.3.2 Hansoh Pharma Business Overview
  16. 6.3.3 Hansoh Pharma Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hansoh Pharma Iloperidone Drugs Product Portfolio
  18. 6.3.5 Hansoh Pharma Recent Developments
  19. 6.4 Inventia
  20. 6.4.1 Inventia Company Information
  21. 6.4.2 Inventia Business Overview
  22. 6.4.3 Inventia Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Inventia Iloperidone Drugs Product Portfolio
  24. 6.4.5 Inventia Recent Developments
  25. 6.5 Taro Pharmaceutical
  26. 6.5.1 Taro Pharmaceutical Company Information
  27. 6.5.2 Taro Pharmaceutical Business Overview
  28. 6.5.3 Taro Pharmaceutical Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taro Pharmaceutical Iloperidone Drugs Product Portfolio
  30. 6.5.5 Taro Pharmaceutical Recent Developments
  31. 6.6 Vanda
  32. 6.6.1 Vanda Company Information
  33. 6.6.2 Vanda Business Overview
  34. 6.6.3 Vanda Iloperidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vanda Iloperidone Drugs Product Portfolio
  36. 6.6.5 Vanda Recent Developments
7 North America by Country
  1. 7.1 North America Iloperidone Drugs Sales by Country
  2. 7.1.1 North America Iloperidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Iloperidone Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Iloperidone Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Iloperidone Drugs Market Size by Country
  6. 7.2.1 North America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Iloperidone Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Iloperidone Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Iloperidone Drugs Sales by Country
  2. 8.1.1 Europe Iloperidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Iloperidone Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Iloperidone Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Iloperidone Drugs Market Size by Country
  6. 8.2.1 Europe Iloperidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Iloperidone Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Iloperidone Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Iloperidone Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Iloperidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Iloperidone Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Iloperidone Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Iloperidone Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Iloperidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Iloperidone Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Iloperidone Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Iloperidone Drugs Sales by Country
  2. 10.1.1 South America Iloperidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Iloperidone Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Iloperidone Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Iloperidone Drugs Market Size by Country
  6. 10.2.1 South America Iloperidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Iloperidone Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Iloperidone Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Iloperidone Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Iloperidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Iloperidone Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Iloperidone Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Iloperidone Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Iloperidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Iloperidone Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Iloperidone Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Iloperidone Drugs Value Chain Analysis
  2. 12.1.1 Iloperidone Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Iloperidone Drugs Production Mode & Process
  7. 12.2 Iloperidone Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Iloperidone Drugs Distributors
  10. 12.2.3 Iloperidone Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst